Nutriband
NTRB----
Nutriband (NTRB)
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentany...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Nutriband Analyst Rating
View MoreForecast & Rating
Apr 6, 2026Price forecast
$15.00387.01%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report · Jul 9 at 09:03 PM
The Market's Island of Misfits: From Golf Courses to Absurd AI Pivots
- Global Report · Jul 9 at 05:03 AM
Unbundling the Long Tail: Narrative Arbitrage and Value Chain Realities
- Global Report · Jul 8 at 10:32 PM
The Island of Misfit Toys: A Microcosm of Wall Street's 2026 Identity Crisis
- TradingView · Jun 22 at 07:13 AM
NutriBand Secures Amended Three-Year $5 Million Credit Line at 7% to Support AVERSA
- PUBT · Jun 22 at 07:04 AM
Nutriband amends $5 million credit line facility at 7% interest
- benzinga_article · Jun 18 at 04:06 PM
12 Health Care Stocks Moving In Thursday's After-Market Session
